Skip to main content
Top
Published in: World Journal of Surgical Oncology 1/2016

Open Access 01-12-2015 | Case report

Recurrence of pancreatic cancer presented as cervical lymphadenopathy

Authors: Hiroshi Nagata, Ken Hayashi, Shigetoshi Yamada

Published in: World Journal of Surgical Oncology | Issue 1/2016

Login to get access

Abstract

Background

We report a case of recurrent pancreatic cancer that presented as cervical lymphadenopathy.

Case presentation

A 69-year-old woman with stage IIb pancreatic cancer underwent a curative Whipple’s procedure after neoadjuvant chemoradiation therapy. Despite adjuvant chemotherapy with S-1, postoperative recurrence was diagnosed as left cervical lymphadenopathy 11 months postoperatively. After she underwent chemoradiation therapy to the cervical area followed by systemic chemotherapy with S-1, the lymphadenopathy became unremarkable 17 months postoperatively. S-1 treatment was discontinued 23 months postoperatively at the patient’s request. She has remained free of disease since that time and has achieved an overall duration of survival of 48 months.

Conclusions

To the best of our knowledge, this is the first reported case of middle cervical lymph node metastasis of pancreatic cancer. Although rare, it should be considered as a site of recurrence. This case suggests concurrent radiation therapy can be a good option for patients who cannot tolerate an aggressive regimen.
Literature
1.
go back to reference Classification of Pancreatic Carcinoma. 3rd English edition ed. 2011: Kanehara & Co. Classification of Pancreatic Carcinoma. 3rd English edition ed. 2011: Kanehara & Co.
2.
go back to reference Sobin L, MKG, Wittekind C, TNM classification of malignant tumours. 7th Edition ed. 2009: Wiley-Blackwell. 336 Sobin L, MKG, Wittekind C, TNM classification of malignant tumours. 7th Edition ed. 2009: Wiley-Blackwell. 336
3.
go back to reference Society JP. Pancreatic Cancer Registry report 2007. Suizo. 2007;22(1):e20–5.CrossRef Society JP. Pancreatic Cancer Registry report 2007. Suizo. 2007;22(1):e20–5.CrossRef
4.
go back to reference Hishinuma S, et al. Patterns of recurrence after curative resection of pancreatic cancer, based on autopsy findings. J Gastrointest Surg. 2006;10(4):511–8.PubMedCrossRef Hishinuma S, et al. Patterns of recurrence after curative resection of pancreatic cancer, based on autopsy findings. J Gastrointest Surg. 2006;10(4):511–8.PubMedCrossRef
5.
go back to reference Saif MW, et al. Pancreatic adenocarcinoma with supraclavicular lymph node metastasis: is this the Virchow’s node? JOP. 2011;12(1):66–7. author reply 70.PubMed Saif MW, et al. Pancreatic adenocarcinoma with supraclavicular lymph node metastasis: is this the Virchow’s node? JOP. 2011;12(1):66–7. author reply 70.PubMed
6.
go back to reference Funakoshi A, Senju T, Sumii T. Two cases of advanced pancreatic cancer with cervical lymph node or liver metastasis responding well to S-1 monotherapy. Jpn J Cancer Chemother. 2006;33(10):1505–9. Funakoshi A, Senju T, Sumii T. Two cases of advanced pancreatic cancer with cervical lymph node or liver metastasis responding well to S-1 monotherapy. Jpn J Cancer Chemother. 2006;33(10):1505–9.
7.
go back to reference Soman AD, et al. Isolated supraclavicular lymph node metastasis in pancreatic adenocarcinoma: a report of three cases and review of the literature. JOP. 2010;11(6):604–9.PubMed Soman AD, et al. Isolated supraclavicular lymph node metastasis in pancreatic adenocarcinoma: a report of three cases and review of the literature. JOP. 2010;11(6):604–9.PubMed
8.
go back to reference Yoshimoto H, NM, Shoju Y, Horii K. An analysis of lymph node metastasis in gingival squamous cell carcinoma. Shika Igaku. 2013;76(1):18–22. Yoshimoto H, NM, Shoju Y, Horii K. An analysis of lymph node metastasis in gingival squamous cell carcinoma. Shika Igaku. 2013;76(1):18–22.
9.
go back to reference Yamaguchi K, et al. EBM-based clinical guidelines for pancreatic cancer (2013) issued by the Japan Pancreas Society: a synopsis. Jpn J Clin Oncol. 2014;44(10):883–8.PubMedCrossRef Yamaguchi K, et al. EBM-based clinical guidelines for pancreatic cancer (2013) issued by the Japan Pancreas Society: a synopsis. Jpn J Clin Oncol. 2014;44(10):883–8.PubMedCrossRef
10.
go back to reference Network NCC. NCCN clinical practice guideline in oncology pancreatic adenocarcinoma version 2. 2015. Network NCC. NCCN clinical practice guideline in oncology pancreatic adenocarcinoma version 2. 2015.
11.
go back to reference Maeda A, et al. Randomized phase III trial of adjuvant chemotherapy with gemcitabine versus S-1 in patients with resected pancreatic cancer: Japan Adjuvant Study Group of Pancreatic Cancer (JASPAC-01). Jpn J Clin Oncol. 2008;38(3):227–9.PubMedCrossRef Maeda A, et al. Randomized phase III trial of adjuvant chemotherapy with gemcitabine versus S-1 in patients with resected pancreatic cancer: Japan Adjuvant Study Group of Pancreatic Cancer (JASPAC-01). Jpn J Clin Oncol. 2008;38(3):227–9.PubMedCrossRef
Metadata
Title
Recurrence of pancreatic cancer presented as cervical lymphadenopathy
Authors
Hiroshi Nagata
Ken Hayashi
Shigetoshi Yamada
Publication date
01-12-2015
Publisher
BioMed Central
Published in
World Journal of Surgical Oncology / Issue 1/2016
Electronic ISSN: 1477-7819
DOI
https://doi.org/10.1186/s12957-016-0773-0

Other articles of this Issue 1/2016

World Journal of Surgical Oncology 1/2016 Go to the issue